IL10 and systemic lupus erythematosus: Further, Avemar decreased inflammation through other immunomodulatory mechanisms, such as decreased production of pro-inflammatory cytokines IL-6 and IL-10 in mice with systemic lupus erythematosus [20, 34] and decreased macrophage infiltration in animal models of rheumatoid arthritis [20, 34].